Campbell & Co Investment Adviser’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.25M | Sell |
25,776
-730
| -3% | -$63.7K | 0.14% | 215 |
|
|
2025
Q1 | $1.81M | Buy |
+26,506
| New | +$1.81M | 0.14% | 226 |
|
|
2024
Q4 | – | Sell |
-14,791
| Closed | -$992K | – | 1122 |
|
|
2024
Q3 | $992K | Buy |
14,791
+4,154
| +39% | +$278K | 0.07% | 443 |
|
|
2024
Q2 | $1.21M | Sell |
10,637
-2,345
| -18% | -$266K | 0.1% | 291 |
|
|
2024
Q1 | $1.8M | Buy |
12,982
+5,374
| +71% | +$745K | 0.16% | 172 |
|
|
2023
Q4 | $944K | Sell |
7,608
-7,730
| -50% | -$959K | 0.09% | 414 |
|
|
2023
Q3 | $1.43M | Buy |
15,338
+10,983
| +252% | +$1.02M | 0.17% | 166 |
|
|
2023
Q2 | $560K | Buy |
4,355
+935
| +27% | +$120K | 0.1% | 376 |
|
|
2023
Q1 | $397K | Buy |
+3,420
| New | +$397K | 0.07% | 503 |
|
|
2022
Q4 | – | Sell |
-3,102
| Closed | -$250K | – | 815 |
|
|
2022
Q3 | $250K | Buy |
+3,102
| New | +$250K | 0.06% | 542 |
|
|
2022
Q1 | – | Sell |
-5,400
| Closed | -$725K | – | 741 |
|
|
2021
Q4 | $725K | Buy |
+5,400
| New | +$725K | 0.25% | 108 |
|
|
2021
Q3 | – | Sell |
-6,000
| Closed | -$641K | – | 630 |
|
|
2021
Q2 | $641K | Buy |
+6,000
| New | +$641K | 0.26% | 98 |
|
|
2020
Q1 | – | Sell |
-13,588
| Closed | -$743K | – | 163 |
|
|
2019
Q4 | $743K | Buy |
+13,588
| New | +$743K | 0.23% | 113 |
|
|
2019
Q3 | – | Sell |
-12,784
| Closed | -$479K | – | 639 |
|
|
2019
Q2 | $479K | Buy |
+12,784
| New | +$479K | 0.22% | 149 |
|
|
2017
Q1 | – | Sell |
-17,140
| Closed | -$256K | – | 166 |
|
|
2016
Q4 | $256K | Buy |
+17,140
| New | +$256K | 0.79% | 55 |
|